Skin abscess in a one-year-old infant;Absceso cutáneo en infante de un año

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 22, Issue 6, 2004, Pages 361-362

  Suárez, Justo Miguel ^a   Herrera, Laura ^b   Bautista, Francisco Javier ^a   Dávila, Jesús ^c  

^a Programa de TBC   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Hospital Punta Europa   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ARTICLE; BACTERIUM CULTURE; BCG VACCINATION; CASE REPORT; HUMAN; INFANT; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; SKIN ABSCESS; SKIN TUBERCULOSIS; TUBERCULIN TEST;

EID: 3142732850     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1157/13063048     Document Type: Article

References (12)

1. Kasai H, Ezaki T, Harayama S. Differentiation of phylogenetically related slowly growing Mycobacteria by theirgyrB sequences. J Clin Microbiol 2000; 38:301-8.
2. Niemann S, Harmsen D, Rüsch-Gerdes S, Richter E. Differentiation of clinical Mycobacterium tuberculosis complex isolates by gyrB DNA Sequence Polymorphism Analysis. J Clin Microbiol 2000;38:321-4.
3. Talbot EA, Williams DL, Frothingham R. PCR Identification of Mycobacterium bovis BCG. J Clin Microbiol 1997;35:566-9.
4. Canetti G, Fox W, Khomenko H. Advances in techniques of testing Mycobacterial drug sensibility, and the use of sensibility test in tuberculosis control programes. Bull WHO 1969;41:21-43.
5. Lotte A, Wasz-Hockert O, Poisson N, et al. Second IUATLD study on complications Induce by intradermal BCG vaccination. Bull Int Union Tuber Lung Dis 1988;63:47-57.
6. Castro-Rodríguez JA, González R, Girardi G. Osteitis caused by bacille Calmette-Guérin vaccination: an emergent problem in Chile. Inf J Tuberc Lung Dis 1997;1:417-21.
7. Lotte A, Wasz-Hockert O, Poisson N, et al. BCG complications estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics. Adv Tuberc Res 1984;21:93-107.
8. Talbot EA, Perkins MD, Silva SF, Frothingham R. Disseminated bacilli Calmette-Guérin disease after vaccination: case report and review. Clin Infect Dis 1997;24:1139-46.
9. CDC.The role of BCG vaccine in the prevention and control of tuberculosis in the United States MMWR Morb Mortal Wkl Rep 1996;45:1-18.
10. Cajlayan S, Yegin O, Kayran K, Timocin N, Kasiaga E, Gun M. Is medical therapy effective for regional linphadenitis following BCG vaccinatiom. Am J Dis Chill 1987;141:1213-4.
11. Goraya JS, Virdi VS. Tratament of Calmette-Guérin bacillus adenitis: a metaanalysis. Pediatr Infect Dis J 2001;20:632-4.
12. a ed. Buenos Aires. Panamericana, 1997; p. 242-50.